CCR2 and influenza: Given that pioglitazone has been shown to attenuate levels of cytokines that act through the CCR2 receptor, and several studies have shown that a deficiency in CCR2 signaling ameliorates the detrimental effects of influenza infection [24], [27], [28], we assessed whether blocking CCR2 signaling would lead to a better outcome in our smoke-exposed mice.